BACKGROUND: Current prescribing information recommends that physicians apply a dose ratio of 1.37:1 (1.53:1 prior to January 2015) in the United States (US) when switching patients with primary ...
KING OF PRUSSIA, Pa., Aug. 9, 2021 /PRNewswire/ — Global biotherapeutics leader CSL Behring today announced that the European Academy of Neurology (EAN) and Peripheral Nerve Society (PNS) Task Force ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results